| |
Pre-therapy
| |
p value
|
During therapy
| |
p value
|
---|
Region
|
UFH (+)
(n = 30)
|
UFH (−)
(n = 8)
| |
UFH (+)
(n = 27)
|
UFH (−)
(n = 11)
| |
---|
SUVmean + 3SD
|
Liver 1
|
3.5 ± 0.4
|
3.6 ± 0.5
|
0.29
|
3.9 ± 0.6
|
3.4 ± 0.5
|
0.03
|
SUVmax
|
Liver 2
|
3.5 ± 0.4
|
3.6 ± 0.4
|
0.76
|
4.0 ± 0.6
|
3.5 ± 0.5
|
0.03
|
DA
|
2.2 ± 0.3
|
2.1 ± 0.3
|
0.76
|
2.3 ± 0.3
|
2.1 ± 0.3
|
0.09
|
SUVmean
|
Liver 2
|
2.7 ± 0.3
|
2.8 ± 0.4
|
0.23
|
3.1 ± 0.5
|
2.7 ± 0.4
|
0.03
|
DA
|
1.9 ± 0.3
|
1.9 ± 0.3
|
0.83
|
2.0 ± 0.3
|
1.8 ± 0.3
|
0.1
|
SUVpeak
|
Liver 2
|
3.0 ± 0.4
|
3.1 ± 0.4
|
0.61
|
3.5 ± 0.6
|
3.1 ± 0.5
|
0.03
|
DA
|
2.0 ± 0.3
|
1.9 ± 0.3
|
0.51
|
2.0 ± 0.3
|
1.9 ± 0.3
|
0.06
|
- SD standard deviation, UFH unfractionated heparin, SUV standardized uptake value, Liver 1 SUV in the liver by semi-automated method, Liver 2 SUV in the liver by manual process, DA descending aorta